Dutch medtech firm Philips reports 3% rise in quarterly sales, meeting estimates
04/11/2025 06:08
Nov 4 (Reuters) - Dutch medical technology company Philips PHG.AS reported third-quarter revenue in line with analysts' expectations un Tuesday, citing a strong performance in North America. The company posted a 3% rise in sales to 4.3 billion euros ($5.0 billion), matching analysts' average estimate in a company-compiled poll. ($1 = 0.8575 euros) (Reporting by Leo Marchandon in Gdansk, editing by Milla Nissi-Prussak) ((Leo.Marchandon@thomsonreuters.com;))
Recent news on Koninklijke Philips
See all newsBrief: Philips Launches Hypervue Integrated System In The U.S., Bringing Advanced Coronary Imaging And Physiology Into The Cathlab
Citi lifts ResMed's ASX-listed stock's target price after FX, valuation updates
Philips wins Dutch court battle with shareholders over recall
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
Brief: SA's Competition Commission Refers GE, Siemens, Philips Units To Tribunal For Alleged Anticompetitive Conduct